Brain Imaging More Effective to Measure Huntington Disease

David Rosenfeld | | Radiology Business | Business Intelligence
Brain imaging techniques could be the most effective way to measure the progression of Huntington Disease, according to a study published this month in The Lancet. Currently, clinical trials involving Huntington Disease require lengthy observation periods of the genetic disorder that effects muscle control and cognitive behavior. But researchers at the University College London believe they have found a more effective way to enhance the development of drugs through MRI. The longitudinal study, known as TRACK-HD, looked at subjects over a two-year period. Researchers believe it’s possible their findings may improve the efficiency of clinical trials. With these latest findings, sample size and trail duration could decrease, resulting in a more refined understanding of the disease. For the study abstract click here. For an in-depth article about the study at Medscape.com click here.

David Rosenfeld

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.